Skip to content
HowShorted

REVIVA PHARMACEUTICALS HOLDINGS, INC. short interest in 2026

In 2026, REVIVA PHARMACEUTICALS HOLDINGS, INC.'s disclosed short interest ran from 20.49% of shares outstanding on 15 Jan 2026 to 14.57% on 30 Apr 2026, a change of -5.92 percentage points. The year's high was 20.58% on 30 Jan 2026 and its low 11.16% on 15 Apr 2026, averaging 16.80% across 7 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.03 days on 13 Feb 2026. Full history: REVIVA PHARMACEUTICALS HOLDINGS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for REVIVA PHARMACEUTICALS HOLDINGS, INC. in 2026

2026 in figures

Start of year
20.49% (15 Jan 2026)
End of year
14.57% (30 Apr 2026)
Change
-5.92 pp
High
20.58% (30 Jan 2026)
Low
11.16% (15 Apr 2026)
Average
16.80%
Highest days to cover
10.03 (13 Feb 2026)
SEC filings marked
6

Every report in 2026

REVIVA PHARMACEUTICALS HOLDINGS, INC. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202620.49%4.85
30 Jan 202620.58%7.68
13 Feb 202619.19%10.03
27 Feb 202617.27%6.18
31 Mar 202614.32%1.2810-K filed, results (8-K)
15 Apr 202611.16%1.95
30 Apr 202614.57%4.90

See also: REVIVA PHARMACEUTICALS HOLDINGS, INC.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.